Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Bassaganya-Riera

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam|June 6, 2013
Preventive and prophylactic mechanisms of action of pomegranate bioactive constituentsMonica Viladomiu, Raquel Hontecillas, Pinyi Lu, et al.
Current Drug Targets|March 18, 2014
Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetesPinyi Lu, Raquel Hontecillas, Casandra W Philipson, et al.
Cellular Immunology|May 9, 2009
PPAR gamma is highly expressed in F4/80(hi) adipose tissue macrophages and dampens adipose-tissue inflammationJosep Bassaganya-Riera, Sarah Misyak, Amir J Guri, et al.
Clinical and Translational Science|January 11, 2025
Safety, Tolerability, and Pharmacokinetics of NIM-1324 an Oral LANCL2 Agonist in a Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialAndrew Leber, Raquel Hontecillas, Nuria Tubau-Juni, et al.
Inflammatory Bowel Diseases|May 3, 2018
Activation of LANCL2 by BT-11 Ameliorates IBD by Supporting Regulatory T Cell Stability Through Immunometabolic MechanismsAndrew Leber, Raquel Hontecillas, Victoria Zoccoli-Rodriguez, et al.
Viral Immunology|August 18, 2010
PPAR-gamma activation as an anti-inflammatory therapy for respiratory virus infectionsJosep Bassaganya-Riera, Rong Song, Paul C Roberts, et al.
Current Opinion in Gastroenterology|September 28, 2016
Translating nutritional immunology into drug development for inflammatory bowel diseaseAndrew Leber, Raquel Hontecillas, Nuria Tubau-Juni, et al.
Inflammatory Bowel Diseases|February 28, 2014
Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?Dario Sorrentino, Peter Nash, Monica Viladomiu, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|September 11, 2015
ENISI SDE: A New Web-Based Tool for Modeling Stochastic ProcessesYongguo Mei, Adria Carbo, Stefan Hoops, et al.
PPAR Research|April 25, 2009
Dietary modulation of inflammation-induced colorectal cancer through PPARγAshlee B Carter, Sarah A Misyak, Raquel Hontecillas, et al.
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Evidence-Based Complementary and Alternative Medicine : Ecam|June 6, 2013
Preventive and prophylactic mechanisms of action of pomegranate bioactive constituentsMonica Viladomiu, Raquel Hontecillas, Pinyi Lu, et al.
Current Drug Targets|March 18, 2014
Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetesPinyi Lu, Raquel Hontecillas, Casandra W Philipson, et al.
Cellular Immunology|May 9, 2009
PPAR gamma is highly expressed in F4/80(hi) adipose tissue macrophages and dampens adipose-tissue inflammationJosep Bassaganya-Riera, Sarah Misyak, Amir J Guri, et al.
Clinical and Translational Science|January 11, 2025
Safety, Tolerability, and Pharmacokinetics of NIM-1324 an Oral LANCL2 Agonist in a Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialAndrew Leber, Raquel Hontecillas, Nuria Tubau-Juni, et al.
Inflammatory Bowel Diseases|May 3, 2018
Activation of LANCL2 by BT-11 Ameliorates IBD by Supporting Regulatory T Cell Stability Through Immunometabolic MechanismsAndrew Leber, Raquel Hontecillas, Victoria Zoccoli-Rodriguez, et al.
Viral Immunology|August 18, 2010
PPAR-gamma activation as an anti-inflammatory therapy for respiratory virus infectionsJosep Bassaganya-Riera, Rong Song, Paul C Roberts, et al.
Current Opinion in Gastroenterology|September 28, 2016
Translating nutritional immunology into drug development for inflammatory bowel diseaseAndrew Leber, Raquel Hontecillas, Nuria Tubau-Juni, et al.
Inflammatory Bowel Diseases|February 28, 2014
Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?Dario Sorrentino, Peter Nash, Monica Viladomiu, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|September 11, 2015
ENISI SDE: A New Web-Based Tool for Modeling Stochastic ProcessesYongguo Mei, Adria Carbo, Stefan Hoops, et al.
PPAR Research|April 25, 2009
Dietary modulation of inflammation-induced colorectal cancer through PPARγAshlee B Carter, Sarah A Misyak, Raquel Hontecillas, et al.
Pageof 14